Bristol Myers Squibb (NYSE: BMY) has announced new topline results from the Phase 3 EMERGENT-4 and EMERGENT-5 open-label trials, which assessed the long-term efficacy, safety, and tolerability of COBENFY™ (xanomeline and trospium chloride) in adults with schizophrenia over 52 weeks…
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and the developer of the Revi® System for urge urinary incontinence (UUI), has announced the publication of a comprehensive meta-analysis in the October issue of Advances in Therapy. Titled “Sacral…
athenahealth, a top provider of network-enabled software and services for healthcare practices across the country, has launched athenaOne for Orthopedics. This comprehensive solution combines EHR, revenue and practice management, and patient engagement features specifically designed for orthopedists. By investing further…
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology company specializing in innovative large-volume subcutaneous infusion solutions, recently shared data highlighting nursing preference for the KORU FreedomEdge® Infusion System for administering subcutaneous oncology infusions in clinical settings. These findings…
Parse Biosciences, a leader in affordable and scalable single-cell sequencing solutions, has launched Parse GigaLab™, designed to enable single-cell sequencing for billions of cells annually. GigaLab utilizes Parse’s Evercode™ technology, enhanced by an expanded workflow and increased automation, facilitating groundbreaking…
ZOLL®, an Asahi Kasei company specializing in medical devices and software solutions, has announced the results of two significant studies on the economic burden of heart failure resulting from severe heart attacks and the long-term cost-effectiveness of SuperSaturated Oxygen (SSO2)…
IKS Health, a provider of healthcare enablement solutions, has partnered with Radiology Partners (RP), a leading U.S. radiology practice. This collaboration utilizes IKS Health’s Gen AI-powered Care Enablement Platform to streamline processes and enhance access to essential imaging services. The…
Castle Biosciences, Inc. (Nasdaq: CSTL) has announced new data highlighting a substantial reduction in healthcare management costs and an enhancement in the quality of life for patients with Barrett’s esophagus (BE) when their care is guided by the TissueCypher test.…
NeuroIntact Inc., a leader in targeted temperature management (TTM) for stroke and traumatic brain injury, has appointed Robert Kline to its Board of Directors. With 25 years of experience in growing innovative companies in the temperature management field, Kline will…
Relief Mental Health, a leader in innovative mental health care, is thrilled to announce the opening of its 11th outpatient clinic in Middleton, Wisconsin, situated at 8333 Greenway Boulevard, Suite 240. Relief Mental Health, a leader in innovative mental health…
Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, has announced the appointment of Dr. Howard McLeod, Pharm.D., FASCO, FCCP, to its Advisory Board. Dr. McLeod is a recognized global leader in precision…
Next Health, recognized as a leader in proactive healthcare, has announced a significant expansion into the Sacramento area, Walnut Creek, and Reno through an area development agreement. This move aligns with Next Health’s growth strategy of establishing thriving centers in…